Tag: Fabienne Kinzelmann

Washington’s pricing mandate is pushing drugmakers to raise European benchmarks and even pull treatments like Roche’s Lunsumio from Switzerland, destabilizing a pharma‑dependent economy and shrinking patient access as companies protect U.S. margins at the expense of smaller markets.